Past Events

09/05/2013– 10/05/2013	Developing a Person-Centered Model of Care for the Patient with Dementia London The conference will bring together leading colleagues working in all areas of dementia care internationally to establish a pathway for the construction of dementia care and services by building upon current work by the international community in the dementia field and enhancing this through the direct application of the principles and recently advanced methods of person-centered care.	Visit Website
06/05/2013– 08/05/2013	Cambridge Heathtech Institute’s Ninth Annual Biomarkers & Diagnostics World Congress 2013 Philadelphia	Visit Website
02/05/2013– 04/05/2013	5th IMPAKT Breast Cancer Conference Brussels The 5th IMPAKT conference on translational research in breast cancer will bring a significant amount of data on the heterogeneity of breast cancer and promises to be a thought-provoking and stimulating experience for participants, partners and stakeholders	Visit Website
30/04/2013– 02/05/2013	World PGx - Harness Genomic Information, Predict Patient Response and Develop Better, Safer Drugs San Francisco	Visit Website
30/04/2013– 02/05/2013	Tumor Imaging in cancer drug development Boston The conference is designed so you can hear from drug developers and imaging experts specially chosen and other leading cancer-focussed organizations. Learn from them. Ask them questions. Discuss your priorities. With the dedicated networking opportunities built into the agenda, you’ll be sure to add these experts to your contact list for future communication and thought-collaboration.	Visit Website
22/04/2013– 25/04/2013	BIO International Convention Chicago Keynotes announced: Debt, Taxes, Government Services and Politics - Is There a Way Out? A Conversation with the co-chairs of President Obama's National Commission on Fiscal Responsibility and Reform.	Visit Website
21/04/2013– 21/04/2013	Annual General Meeting of the European Cancer Patient Coalition Brussels	Visit Website
10/04/2013– 11/04/2013	Biomarqueurs B4B-Connection Paris Biomarqueurs or not Biomarqueurs telle n'est plus la question ! Quel avenir pour les biomarqueurs ? Quelle révolution pour la médecine ? Voici 10 ans, les pharmas qui croyaient aux biomarqueurs pour leur développement se comptaient sur à peine les doigts d'une main. Désormais, pas une ne lui tourne vraiment le dos. Certaines ont déjà plongé, en avance sur les autres, d'autres y ont engagé un bras, d'autres s'intéressent sérieusement au plongeon.	Visit Website
09/04/2013– 11/04/2013	Connecting Healthcare IT Berlin Find out about the latest developments in Healthcare IT. The Industrial Fair, Congress, Academy and Networking Events all gave exhibitors and visitors daily opportunities to exchange views, broaden their knowledge and put forward their own topics.	Visit Website
22/03/2013– 23/03/2013	Symposium “Biomarkers of Ageing” 2013 Konstanz This symposium will be held on the occasion of the final meeting of the Mark-Age Consortium. Mark-Age is an EU FP7 Project aiming at the identification of biomarkers of human ageing.	Visit Website
20/03/2013– 22/03/2013	GTC Biomarker Summit 2013 San Francisco The summit will discuss a wide range of issues such as biomarker identification and validation strategies, patient stratification, enabling omics technologies, bioinformatics and systems biology techniques, regulatory and reimbursement trends and the development of companion diagnostics. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector	Visit Website
20/03/2013– 21/03/2013	Conference on Innovation and Patient Access to Personalised Medication Dublin The meeting will bring together researchers, patients, physicians, regulators and politicians, to explore the current barriers and how they can be dismantled.Expert panels will examine potential ways through the obstacles that Europe currently poses - in relation to clinical trials, the links between diagnosis and treatment, reimbursement, training of healthcare professionals, and sharing of data.	Visit Website
19/03/2013– 21/03/2013	World CDx Frankfurt. Advance your commercial strategies, improve clinical efficacy and get to market Frankfurt World CDx Frankfurt brings together the leading minds to discuss these rapid advances and crucially, how you can use these approaches to increase confidence and speed in your CDx development. Featuring case studies from the largest and most successful Rx/Dx partnerships you can learn from their experiences and significantly reduce overall development time.	Visit Website
14/03/2013– 15/03/2013	2013 Lung Cancer Conference - Lung Cancer Treatment in the Era of Personalised Medicine (seminar) Luxembourg The 2nd Lung Cancer Conference will bring together in Luxembourg some of the world leading experts in lung cancer to discuss recent advances and to explore new avenues for research.	Visit Website
13/03/2013– 14/03/2013	Imaging in Cancer Drug Development London A unique opportunity to witness presentations on the current developments surrounding: oncology and diagnostic imaging modalities, drug development and clinical development alongside networking with key industry professionals.	Visit Website
07/03/2013– 10/03/2013	1st International Congress on Controversies in Personalized Oncology (CONPO) Barcelona Main topics: Whole genome sequencing vs. selected genes NGS, Epigenetic vs. Genomics, Design clinical trial in an era of personalized oncology, Treatment decisions based on gene mutations vs. disease origin, Gene signatures for disease classification, Histopathology vs. Modern Molecular DX, CTC as a prognostic and treatment monitoring tool, Gene to drug development, Small molecules vs. Abs	Visit Website
04/03/2013– 06/03/2013	Targeted Anticancer Therapies (TAT) Congress 2013 Paris Unique series "International Congress on Targeted Anticancer Therapies" (TAT), which is devoted to the most promising targeted cancer therapeutics. TAT meetings are leading oncology phase 1 meetings in Europe and a must-attend for clinical investigators, research scientists and drug development professionals in pharma, biotech and CROs	Visit Website
27/02/2013– 02/03/2013	State-of-the-Art Molecular Imaging in Cancer Biology and Therapy San Diego This first joint meeting between the AACR and the Society of Nuclear Medicine and Molecular Imaging will bring together imaging scientists with biologists in basic, translational, and clinical research to explore how new findings in molecular imaging can improve cancer diagnostics, treatment, and patient outcomes. Sessions will cover areas of cancer biology that currently, or will potentially, interface with molecular imaging technologies and/or imaging agent development.	Visit Website
27/02/2013– 27/02/2013	Biobanking 2013 London Biobanking 2013 will discuss the banking of Biospecimens used for basic research through clinical trials. Efficient and effective collection, processing, storage, and tracking of biospecimens will be discussed. Bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners this event will investigate the best methods for effective use of biospecimens in the 21st Century.	Visit Website
21/02/2013– 23/02/2013	EASL Monothematic Conference: Systems Biology of the Liver: Systems Biology and Clinics Face-a-Face Luxembourg First dedicated liver meeting with a focus on systems biology. This timely conference aims to contribute to a European platform for systems biology and genetics of liver diseases.	Visit Website
19/02/2013– 20/02/2013	8th Annual Biomarkers Congress 2013 Manchester, UK 6 Interactive Streams: Biomarker Discovery & Development,Companion Diagnostics & Personalised Medicine, Biomarkers in Clinical Development, Enabling Technologies & Identification, CNS Biomarkers, CNS Case Studies	Visit Website
14/02/2013– 15/02/2013	Relationship between genome and epigenome Brussels, european commission This COST and European Commission Research & Innovation Framework Programme workshop will bring together scientists from the COST Actions and from the European Commission’s Seventh Framework Programme (FP7) to discuss the link between genome and epigenome.	Visit Website
11/02/2013– 15/02/2013	Molecular Med TRI-CON 2013 San Francisco Cambridge Healthtech Institute's Flagship Event. The 2013 event is celebrating 20 years of advancing applied science and technology. Early bird registration by November 9.	Visit Website
04/02/2013– 04/02/2013	Building a Framework for Societal Benefits Approach to Health Technology Assessment Brussels The event aims to bring together patinets' organisations, science and industry to discuss the ethical and economical implications of building a societal benefits approach to health technology assessment (HTA).	Visit Website
03/02/2013– 05/02/2013	Biomarkers for Brain Disorders: Challenges and Opportunities Cambridge The conference aims to bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs	Visit Website
31/01/2013– 01/02/2013	2nd Annual Biotech Clinical Outsourcing Partnerships Brussels Small and medium sized biotechs will have the opportunity to interact with large pharma representatives, exchange best practices and discuss challenges in outsourcing.	Visit Website
13/12/2012– 13/12/2012	Colloque “Biomarqeurs: vers une médecine personnalisée” Centre des Congrès, Caen, France Au cours de ce colloque, centré sur les pathologies neurologiques (maladie d’Alzheimer en particulier) et les cancers, seront abordés deux thèmes principaux. Le premier concerne l’imagerie biomédicale et en particulier le développement de radiotraceurs et de produits de contraste pour l’imagerie par émission de positons (TEP) et l’imagerie par résonance magnétique (IRM) et leurs applications ; l’autre porte sur l’intérêt de l’analyse globale du métabolome, associée à celle du génome, du transcriptome et du protéome, pour l’identification de biomarqueurs utilisables dans le contexte d’une médecine personnalisée.	Visit Website
04/12/2012– 06/12/2012	4th World Epigenetics Summit London, United Kingdom The summit is part of a series of international healthcare events that are held in Africa, Asia, Europe and the Middle East. Building on the success of previous events the summit will help develop an understanding of the challenges faced by global health professionals throughout the world, as well as a knowledge-sharing platform on innovative solutions and strategies for public health organisations.	Visit Website
29/11/2012– 30/11/2012	The Global Healthcare Summit 2012 Park Plaza Victoria, London The summit is part of a series of international healthcare events that are held in Africa, Asia, Europe and the Middle East. Building on the success of previous events the summit will help develop an understanding of the challenges faced by global health professionals throughout the world, as well as a knowledge-sharing platform on innovative solutions and strategies for public health organisations.	Visit Website
28/11/2012– 29/11/2012	8th Annual Personalized Medicine Conference Harvard Medical School, Boston, MA This year's two-day conference will once again bring the most current updates on Personalized Medicine and how recent experience may guide and inform the policies, plans and actions of stakeholders among government, academe and the private sector. Widely considered the premier event in the field, the conference attracts over 600 national and international thought leaders. The conference reflects a distinctive collaboration of the Partners HealthCare Center for Personalized Genetic Medicine, Harvard Medical School and Harvard Business School. The alliance of these renowned academic enterprises presents an exceptional opportunity to address the integrating of medicine and business in facilitating personalized medicine.	Visit Website
22/11/2012– 22/11/2012	Life Science Frontiers. Bridging the gap between Science and Healthcare Uppsala, Sweden The gap between biomedical science and the healthcare industry is growing in Europe, as in much of the world. But Europe’s healthcare systems are not keeping pace. Still organised around doctors and hospitals, they are struggling to keep costs under control and improve outcomes. In turn, Europe’s life sciences industry fears it will lose its innovative edge in an age of government austerity, tighter regulations and falling R&D productivity. This event will explore radical and innovative ways of bringing together science and healthcare to address the challenge of creating high-quality patient-centric care at an affordable price. Leading international biomedical researchers will join industry leaders, policy-makers and healthcare experts for a day of high-level debate where thought-provoking case studies of initiatives and innovation will act as catalysts for discussion. Life Science Frontiers will ask the difficult questions, stimulating fresh thinking and new approaches towards both	Visit Website
22/11/2012– 22/11/2012	EDMA Workshop on the future IVD Regulation Brussels, Belgium EDMA is organising this workshop to discuss all the key aspects and general concepts of the upcoming IVD Regulation and highlight the possible issues and areas of change which impact IVD manufacturers. During the workshop the proposals for possible amendments will be also discussed.	Visit Website
22/11/2012– 23/11/2012	2nd Munich Biomaker Conference Munich, Germany The conference wil present latest biomarker research and discuss various aspects of personalized medicine in panel discussions and workshops. BioM, Munich and EuroBioForum have also joined forces to develop a transregional strategic agenda to initiate partnerships between regions on topics of joint interest and identify unmet needs in the area of Personalised Medicine. BioM and EuroBioForum will organise a first satellite meeting to the conference.	Visit Website
20/11/2012– 20/11/2012	What is communicating science for you? Fokker Terminal, The Hague Communication is at the heart of everything we do. It is even at the heart of life itself. From biological pathways to human interaction, communication is what keeps everything moving. As communication comes so natural to us, most of the times we hardly think about how we do it. That is unfortunate, because how we communicate is often as important as what we communicate. To get a grip on our modes of communication and learn how to improve our efforts in this respect, this year’s Life Sciences Momentum will zoom in on the how, when, where, why and what of communicating science.	Visit Website
13/11/2012– 13/11/2012	Health Research at a Crossroads – Are Public-Private Partnerships the Way Forward? European Parliament, Brussels Health research is at a crossroads. Developing new drugs for the many diseases and conditions that still lack a cure or effective treatment is proving extremely difficult, leading some pharmaceutical companies to give up on entire disease areas. Meanwhile, budgets for drug research and development are tighter than ever. Are public-private partnerships (PPPs) the way forward? Or would other models offer a better solution?	Visit Website
12/11/2012– 14/11/2012	18th Annual International Partnering Conference BIO-Europe 2012 CCH Congress Center, Hamburg "The congress will focus on clinical debates in: diagnosis, treatment and prevention of neurological diseases; epidemiology of neurological diseases; health service delivery, health policy and health economics; translational neuroscience; improving outcomes for people with neurological disease. Presentations include: Imaging Genetics: the new frontier in neuroepidemiology; Gene-environment interactions; inovative methods in diagnosing and managing neurological diseases"	Visit Website
06/11/2012– 07/11/2012	4th Annual Personalised Medicine conference - “The Business of Personalised Medicine” Cumberland Lodge, Windsor, UK Topics: Meeting current healthcare challenges through personalised medicine. Personalised medicine: making it work. Integration of technologies. Personalised medicine as part of broader personalised healthcare. Lessons from out-side pharma. Achieving success in a cash-strapped world	Visit Website
12/10/2012– 13/10/2012	Innova Health Conference Golden Bay Beach Hotel, Larnaca, Cyprus The main issue to be discussed during the conference is open innovation in the area of Health, placing particular emphasis on personalised medicine, preventive health, e-health and nutrition. Competent Ministry and Authority: Ministry of Health, Institute of Neurology and Genetics	Visit Website
08/10/2012– 09/10/2012	EMA workshop on Pharmacogenomics: from science to clinical care EMA London The European Medicines Agency is hosting a two-day workshop on pharmacogenomics impact on public health and opportunities for new treatment models based on prediction and prevention. Objectives of the planned workshop: Share international expert views on pharmacogenomic applications in clinical development, approval and patient’s access to medicines, Discuss challenges and bottlenecks, Identify areas for regulators and other stakeholders’ joint actions :	Visit Website
30/09/2012– 02/10/2012	6th Santorini Conference «Biologie Prospective» Santorini, Greece co-organized with the European Society of Pharmacogenomics and Theranostics (ESPT), this conference will brings the following topics Prediction of risks, particularly in multifactorial diseases,evaluation of environmental risks, and pharmacogenomic (measuring the individual responses to drugs)	Visit Website
26/09/2012– 26/09/2012	Standards in the biomedical technologies sector: Challenges & opportunities for the national market! Chamber of Commerce, 7 rue Alcide de Gasperi, L-1615 Luxembourg-Kirchberg Linked with the priorities fixed by the government of the Grand-Duchy of Luxembourg, the National Standards Body, ILNAS, carries on a standards analysis of the biomedical technologies sector. As a first step, an inventory of the active technical committees of the biomedical technologies sector was conducted at European and International level. In parallel, an identification of national stakeholders potentially concerned was performed to establish correlations with the standards watch results. The interests and opportunities for the national market pointed out through this analysis will be presented during the conference. A round-table with stakeholders will take place to exchange on the potential benefits to participate in standardization in the biomedical sector. In addition, in order to pursue this initiative, the options offered by ILNAS to be active in the standardization process in Luxembourg will be presented.
18/09/2012– 18/09/2012	European Alliance for Personalised Medicine Meeting European Parliament, Brussels Speakers will include: Commissioner Dalli, Permanent Representatives, MEPs, Chairs of the Alliance. The meeting will address the following key policy areas: Ensuring a regulatory environment which allows early patient access to novel and efficacious personalised medicine. Increasing research and development for personalised medicine. Improving the education and training of healthcare professionals. Acknowledging new approaches to reimbursement and HTA assessment, which are required for patient access to personalised medicine and its value to be recognised. Increasing awareness and understanding of personalised medicine	Visit Website
12/09/2012– 13/09/2012	The 4th Annual Personalized Medicine Conference Boston, MA The Practice of Personalized Medicine: Payors, Evidence, and the Clinical Application of Personalized Medicine: Clinical delivery of personalized medicine, Whole Genome Sequencing in practice of medicine, Coding & reimburmsent for companion diagnostics, Clinical application of personalized medicine, Economics of personalized medicine, Medicare coverage for companion diagnostics, Market access challenges for companion diagnostics	Visit Website
21/08/2012– 23/08/2012	Next Generation DX Summit Hyatt Regency Washington on Capitol Hill - Washington, DC The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization.	Visit Website
18/06/2012– 19/06/2012	First Annual Health Economics and Personalized Medicine Symposium Luxembourg City, Luxembourg Creating a Personalized Medicine paradigm for oncology. In a highly interactive format, key opinion leaders will identify and discuss policies and programs that could facilitate the adoption high value personalized medicine technologies, while at the same time avoiding adoption of low value technologies. Internationally renowned leaders in personalized medicine and health economics will present research and commentary on the most pressing needs at the intersection of these two disciplines.	Visit Website
05/06/2012– 07/07/2012	Euromediag International Convention 2012 - Jeudi 5 et vendredi 6 juillet 2012 à Montpellier SupAgro Convention internationale sur le diagnostic et la médecine personnalisée – EIC 2012	Visit Website
10/05/2012– 11/05/2012	4th Annual Translational Medicine Conference City Hotel, Derry/Londonderry, Northern Ireland 'Inflammatory Processes and Cardiovascular Disease - Innovative Healthcare for Challenging Times'	Visit Website
10/05/2012– 11/05/2012	Molecular Diagnostics Europe London, UK Diagnostic Applications of Exosomes, Point of Care Diagnostics, Disease Biomarkers and Circulating Tumor Cells conferences and exhibition	Visit Website
03/05/2012– 05/05/2012	IMPAKT 2012 Breast Cancer Conference Brussels, Belgium Vincent Fert IMProving CAre and Knowledge through Translational Research - The IMPAKT Breast Cancer Conference is the leading translational research meeting in the field. The delegates are mainly medical oncologists and scientists working in the translational research setting. The identification of relevant biomarkers and their application in the personalized management of breast cancer is the main theme of the conference. We are introducing several new important topics, including: a session on biomarker guidelines; a joint session with the European Society of Pathology; and a satellite session on ‘Biomarker Approval and Reimbursement Policies’ in the personalized medicine setting. The conference is also an excellent networking opportunity for the profession and industry.	Visit Website
03/05/2012– 04/05/2012	Luxembourg Health Summit Luxembourg City, Luxembourg Meet Emmanuelle Benzimra Executive Director of EPEMED The Ministry of Health and the Personalized Medicine Consortium (PMC) of Luxembourg are cordially inviting the grand public of Luxembourg to attend a ground-breaking national health summit on 3rd May 2012 from 8.00 am to 2.00 pm at the Chamber of Commerce of Luxembourg.	Visit Website
18/04/2012– 20/04/2012	Public Health Genomics - European Networks Rome, Italy Meet Emmanuelle Benzimra Executive Director of EPEMED The Public Health Genomics European Network (PHGEN) is the cornerstone in the development of Public Health Genomics in Europe. It is funded by the European Commission General Directorate for Health and Consumer Protection (DG SANCO) under the Health Programme. PHGEN II produces the first edition of “European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies”.	Visit Website
21/02/2012– 23/02/2012	Molecular Med TRI-CON Moscone North Convention Center- San Francisco, USA Peter Collins	Visit Website
16/02/2012– 18/02/2012	Omics and Personalised Health EMBL Heidelberg, Germany It addresses the promises and challenges of bringing systems biology research into medical practice. This EMBL conference offers an unusually rich opportunity to hear from, and interact with, leaders in the efforts directed as molecular approaches to personalized health.	Visit Website
19/01/2012– 20/01/2012	Personalised Health Care: From Theory to Practice London After years of development, personalised health care is starting to move into clinical practice - and patients, healthcare providers and payers could all benefit. This conference highlights: Case studies - where, and in for what indications, has it been shown to work already? Modeling - What would be the public health impact be if scaled up across an entire country or the European Union? Management - How should health authorities adapt to maximise the benefit and minimise the cost? Investment - What companies, large and small, will be first to capitalise on this opportunity? International - How can EU coordination, and international collaboration, speed adoption?	Visit Website
18/01/2012– 20/01/2012	Overcoming Regulatory and Commercialisation Challenges for Personalised Medicines Vienna, Austria Alain Huriez-Chairman Integrating Rx/Dx business models and achieving R&D objectives for targeted therapies and companion diagnostics	Visit Website
14/12/2011– 15/12/2011	Advancing Genomics into Personalized Medicine Free online Webinar Time: 1:30 pm EST, 10:30 am PST, 6:30 pm GMT Genetic Engineering & Biotechnology News presents an educational and informative webinar on Personalized Medicine	Visit Website
08/12/2011– 08/12/2011	Conference: Personalised Medicine in Europe : What will it take to succeed? Hotel Novotel Luxembourg-Kirchberg, Luxembourg EPEMED and The Luxembourg Life Sciences Initiative registration will be available soon	Visit Website
05/12/2011– 07/12/2011	3rd Molecular Diagnostics for Cancer Drug Development Franckfurt, Germany	Visit Website
16/11/2011– 17/11/2011	WEBINAR 16 Nov. 2011, Nutrigenomics and Health / Personalised Healthcare Free on line webinar 16.00pm Central European Time/ 10:00am Eastern Time United States Chairman Patrick Terry	Visit Website
15/11/2011– 17/09/2011	World Theranostics Congress 2011 San Diego, USA Peter Collins	Visit Website
15/11/2011– 17/11/2011	World Theranostics Congress 2011 San Diego, USA Peter Collins	Visit Website
14/11/2011– 17/11/2011	WORLDx Congress Boston, Massachusetts USA Mara Aspinall
09/11/2011– 10/11/2011	Harvard Personalized Medicine Conference Boston, MA USA Mara Aspinall Case Study: Sequencing – Fact and Fiction	Visit Website
26/10/2011– 28/10/2011	Emtech, MIT Technology Review Conference Malaga, Spain Mara Aspinall on Emerging Technologies (Emtech)	Visit Website
25/10/2011– 27/10/2011	2nd World Pharmacogenomics Summit Munich, Germany Alain Huriez (Speaker) Using Genomic Technology and Information to Support Drug Development	Visit Website
20/10/2011– 21/10/2011	Connected Health Symposium Boston, MA USA Mara Aspinall Personalized Medicine & Connected Health: The Accelerating Convergence of Genomics, Information Technology, and Healthcare?	Visit Website
11/10/2011– 13/10/2011	Molecular Diagnostics Summit Europe Hannover, Germany Alain Huriez (Speaker & Key note speaker) Molecular Diagnostics For Personalized Medicine - Reimbursement policies and the future of Personalized Medicine in Europe	Visit Website
05/10/2011– 06/10/2011	Capitol Hill Briefing Washington DC USA Mara Aspinall Personalized Medicine: Accelerating Its Promise to Advance Cancer Care
21/09/2011– 23/09/2011	Pharmaceutical Strategic Alliances Conference New York City, USA Iain Miller (panelist)	Visit Website
07/09/2011– 09/09/2011	BioPharm America 2011 Boston, Massachusetts USA Mara Aspinall	Visit Website
01/09/2011– 02/09/2011	Institute of Industrial Engineers Annual Conference & Expo Boston, Massachusetts USA Mara Aspinall
31/08/2011– 03/09/2011	EMBC’11 Boston, MA, USA Meet EPEMED representative : Mara Aspinal Integrating Technology and Medicine for a Healthier Tomorrow	Visit Website
23/08/2011– 25/08/2011	Next Generation Dx Summit, Washington DC, USA Alain Huriez and Patrick Terry Commercialization of Molecular Diagnostics	Visit Website
01/08/2011– 03/08/2011	Grand Rounds, Stanford University School of Medicine Stanford CA, USA Mara Aspinall	Visit Website
18/07/2011– 20/07/2011	World Dx Congress Baltimore, MD ,USA Patrick Terry and Mara Aspinal Taking advances of biomarkers and Personalized Medicine From Microscope to Market	Visit Website
01/07/2011– 02/07/2011	Aspen Idea Institute Festival: Aspen, Colorado Aspen, Colorado USA Mara Aspinall Frontiers of Medicine	Visit Website
28/06/2011– 30/06/2011	Molecular Diagnostics for Cancer Drug Development Boston MA, USA Iain Miller	Visit Website
28/06/2011– 30/06/2011	BIO 2011 - Diagnostic & Personalized Medicine Washington DC, USA Patrick Terry and Iain Miller	Visit Website
23/06/2011– 24/06/2011	Genetic Alliance - Regulation of Laboratory Developed Testing Washington DC, USA Patrick Terry	Visit Website
14/06/2011– 16/06/2011	World Theranostics congress Geneva, EUROPE Iain Miller	Visit Website
03/06/2011– 07/06/2011	ASCO Chicago, USA Iain Miller	Visit Website
25/05/2011– 25/05/2011	- EPEMED webinar 2011 - Building the European Personalised Medicine Market The webinar, moderated by Dr. Iain Miller , a co-founder and board member of EPEMED, and Executive Director of Theranostics at bioMerieux, featured the following industry panelists: Dr. Iain Miller, "Market Access Challenges in the EU for High Medical Value Diagnostics Tests"; Nick Crabb, Associate Director, Diagnostics Assessment Program, NICE "Assessment considerations for companion diagnostic products" ; and Loic Kubitza, PWC " The opportunities and challenges of European market entry for emerging diagnostics companies ". Follow the link to register	Visit Website
24/05/2011– 24/05/2011	Personalized Diagnostics Seminar Tokyo Japan Patrick Terry
19/05/2011– 21/05/2011	Convergence East, the Life Sciences Leaders Forum, USA Chatham MA, USA Mara Aspinall	Visit Website
12/05/2011– 13/05/2011	European perspectives in personalised medicine Bruxelles, Belgium Speaker : Alain Huriez. Meet us at the mini-fair : Alain Huriez, Pierre Etienne Sado, and Alice Le Bars The conference will take stock of the recent achievements in health related research leading to personalised medicine and will aim at identification and prioritisation of future actions needed at the European level, bringing together European and national – level policy makers, industrial and academic researchers, patients, clinicians and other stakeholders. The conference programme is based on the conclusions of a series of workshops on personalised medicine organised in 2010.	Visit Website
11/05/2011– 12/05/2011	B4B-Connection Medecine Predictive et Personnalisee Paris, France Vincent Fert	Visit Website
02/05/2011– 05/05/2011	Biomarker World Congress Philadelphia PA, USA Iain Miller	Visit Website
27/04/2011– 27/04/2011	IQPC Companion Diagnostic Forum Philadelphia PA, USA Patrick Terry	Visit Website
14/03/2011– 15/03/2011	BIO-EUROPE Spring Milan, Italy Alain Huriez Breaking Ground in Personalized Medicine: What Do the Recent Deals Mean for Drug Development?	Visit Website
12/10/2010– 12/10/2010	Personalised Medicine in France and in Europe: a major health economic challenge for the next decade Paris, France Alain Huriez; Vincent Fert, Patrick Terry; Iain Miller and Ann Bruinvels. Private conference. The purpose of the meeting was to inform and educate policy makers, industrial players and other interested parties on the broad challenges associated with access to personalized medicine in Europe, with a particular emphasis on France. It was hosted by French Senator Philippe Adnot, member of the Finance Committee, who introduced the conference together with the French Member of Congress Claude Birraux. The conference attracted a diverse group of attendees from Europe and the United States. The meeting was structured as a plenary session presented by EPEMED’s chairman Dr Alain Huriez, followed by a series of 3 round tables, together with several presentations followed by a discussion of the role of French industry.
15/09/2010– 15/09/2010	EPEMED Webinar 2010 - Market Access for Personalised Medicine in Europe - / Speakers: Mr Joe Ferrara (Boston Healthcare); Ms Rasika Ramachandran (Frost & Sullivan); Dr Alain Huriez (Founder EPEMED). Moderated by Dr Anne Bruinvels, Executive Director EPEMED